Decision: Favourable

Decisions Table

Study Title:

A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature.

  • NREC Code:

    22-NREC-CT-094

  • Decision:

    Favourable

  • Meeting Date:

    11/04/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Susan O'Connell

  • PI Institution:

    Children's Health Ireland at Crumlin

  • Sponsor:

    Novo Nordisk Ltd

Scroll to Top